Spring 2024 – LEX takes delivery of final pre-production prototypes
About us
LEX Diagnostics is a privately held molecular diagnostics company developing products designed to enhance patient care by delivering clinical insights within minutes and at the time they are most valuable. Delivering a high-speed molecular test will redefine point-of-care diagnostics.
Our ultra-fast thermal cycling technology delivers sensitive PCR results directly from a swab sample in a user-friendly system. The LEX Diagnostics system fits seamlessly into primary care workflows, bringing the sensitivity of PCR to urgent care centres, physician’s office labs and pharmacies and at a much lower cost per test than competing molecular offerings.
History
LEX Diagnostics Ltd was founded in 2020, as a spin out from TTP plc, a leading life sciences technology and product development company founded in 1988 and active in the development of point-of-care diagnostics for more than 20 years.
We are based on the Melbourn Science Park, near Cambridge, UK.
2024
Spring 2024 – Team size increasing with focus on completing development and preparations for clinical studies.
2023
Winter 2023 – LEX secures significant funding with a third party investor
November 2023 – LEX takes delivery of its near final prototypes
July 2023 – LEX appoints Heather Danks as its CTO
January 2023 – LEX appoints Ed Farrell as its new CEO
Building the team for the next stage in our journey.
2022
August 2022 – Commences ISO13485 certification activities
Appoints experienced Quality Manager to guide and support the team as we prepare for ISO13485 certification.
2022: Reagent production laboratory and lyophilisation capacity expanded
Enhances in-house reagent lyophilisation capacity to support the demand of a growing R&D programme.
April 2022 – Reagent production laboratory and lyophilisation capacity expanded
Enhances in-house reagent lyophilisation capacity to support the demand of a growing R&D programme.
2021
September 2021 – LEX receives core patent grant from USPTO
The core innovation making 5 minute sample-to-answer possible is secured.
May 2021 – LEX establishes 100k/yr manufacturing line for its consumables
Secures supply for development and clinical studies and starts the journey towards high volume manufacturing.
2020
September 2020 – LEX expands the scientific team and builds new facilities
Grows and brings in-house key capabilities including custom reagent development, bioinformatics and the
manufacture of medical consumables.
February 2020 – LEX Diagnostics Ltd founded as an independent company within the TTP Group
Following successful technology demonstration TTP Group invests core intellectual property and key staff into a dedicated company with a mission to commercialise an ultrafast point-of-care diagnostic for respiratory viruses.
2018
July 2018 – Invention of ultra-fast thermal cycling technology
An internal TTP project invents a low cost, rapid thermocycling technology based on the understanding that PCR speed is not limited by biology, but by thermal cycling speed